These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 12174909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination antigene therapy targeting c-myc and c-erbB(2) in the ovarian cancer COC(1) cell line.
    Fei R, Shaoyang L.
    Gynecol Oncol; 2002 Apr; 85(1):40-4. PubMed ID: 11925118
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 6. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M.
    Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535
    [Abstract] [Full Text] [Related]

  • 7. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
    Yu BW, Nguyen D, Anderson S, Allegra CA.
    Anticancer Res; 1997 Oct 01; 17(6D):4407-13. PubMed ID: 9494542
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
    Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM.
    Carcinogenesis; 2004 Mar 01; 25(3):333-41. PubMed ID: 14604889
    [Abstract] [Full Text] [Related]

  • 9. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC, Chen ZJ, Prabhu SS, Loudon WG, Gillies GT, Phillips LL, Fillmore H.
    Neurosurgery; 1997 Oct 01; 41(4):908-15. PubMed ID: 9316053
    [Abstract] [Full Text] [Related]

  • 10. Perspectives on antisense therapy for the prevention of restenosis.
    Kipshidze N, Moses J, Shankar LR, Leon M.
    Curr Opin Mol Ther; 2001 Jun 01; 3(3):265-77. PubMed ID: 11497351
    [Abstract] [Full Text] [Related]

  • 11. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
    Galderisi U, Di Bernardo G, Melone MA, Galano G, Cascino A, Giordano A, Cipollaro M.
    J Cell Biochem; 1999 Jul 01; 74(1):31-7. PubMed ID: 10381259
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.
    Abaza MS, Al-Saffar A, Al-Sawan S, Al-Attiyah R.
    Tumour Biol; 2008 Jul 01; 29(5):287-303. PubMed ID: 18802399
    [Abstract] [Full Text] [Related]

  • 16. c-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: in vitro and in vivo studies of uptake, effects, and toxicity.
    Chu SH, Zhang H, Ma YB, Feng DF, Zhu ZA, Yuan XH, Li ZQ.
    J Surg Res; 2007 Aug 01; 141(2):284-8. PubMed ID: 17561117
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer.
    Akie K, Dosaka-Akita H, Murakami A, Kawakami Y.
    Antisense Nucleic Acid Drug Dev; 2000 Aug 01; 10(4):243-9. PubMed ID: 10984118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
    Rudin CM, Kozloff M, Hoffman PC, Edelman MJ, Karnauskas R, Tomek R, Szeto L, Vokes EE.
    J Clin Oncol; 2004 Mar 15; 22(6):1110-7. PubMed ID: 15020613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.